Comments
Loading...
ACADIA Pharmaceuticals (NASDAQ:ACAD) Stock, Earnings Estimates, EPS, And Revenue
ACADIA Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Feb 25
EPS Estimate
$0.230
Quarterly Revenue Estimate
$282.92M
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$929.24M
Analyze the earnings history of ACADIA Pharmaceuticals using advanced sorting and filters.
Data brought to you by Benzinga APIs
ACADIA Pharmaceuticals (ACAD) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-06 | $0.20 | $0.14 | 42.9 % |
| Q2 | 2024-08-06 | $0.20 | $0.19 | 5.26 % |
| Q1 | 2024-05-08 | $0.10 | $0.05 | 100.0 % |
| Q4 | 2024-02-27 | $0.28 | $0.30 | -6.67 % |
ACADIA Pharmaceuticals (ACAD) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | 2024-11-06 | $250.40M | $248.81M | 0.64 % |
| Q2 | 2024-08-06 | $241.96M | $236.00M | 2.53 % |
| Q1 | 2024-05-08 | $205.83M | $208.36M | -1.21 % |
| Q4 | 2024-02-27 | $231.04M | $223.70M | 3.28 % |
FAQ
When is ACADIA Pharmaceuticals (NASDAQ:ACAD) reporting earnings?
ACADIA Pharmaceuticals (ACAD) is scheduled to report earnings on February 25, 2025. The last reported earnings were for reported on November 6, 2024 for Q3.
What were the latest earnings per share (EPS) for ACADIA Pharmaceuticals (NASDAQ:ACAD)?
The Actual EPS was $0.20, which beat the estimate of $0.14.
What were ACADIA Pharmaceuticals’s (NASDAQ:ACAD) revenues?
The Actual Revenue was $250.4M, which beat the estimate of $248.8M.
Browse earnings estimates, EPS, and revenue on all stocks.